A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
Public ClinicalTrials.gov record NCT04766476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-963272 compared to placebo in participants with nonalcoholic fatty liver disease (NAFLD) and high probability of advanced fibrosis.
Study identification
- NCT ID
- NCT04766476
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 9 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2021 (Actual)
- Primary completion
- Aug 12, 2021 (Actual)
- Completion
- Aug 12, 2021 (Actual)
- Last update posted
- Jun 9, 2022
2021
United States locations
- U.S. sites
- 19
- U.S. states
- 8
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cullman Clinical Trials | Cullman | Alabama | 35055 | — |
| Local Institution | Chandler | Arizona | 85224 | — |
| Arizona Liver Health - Tucson | Tucson | Arizona | 85712 | — |
| Local Institution | Boca Raton | Florida | 33434 | — |
| RecioMed Clinical Research Network | Boynton Beach | Florida | 33472 | — |
| Local Institution | Miami | Florida | 33014 | — |
| Advanced Pharma - Miami | Miami | Florida | 33147 | — |
| Floridian Clinical Research | Miami Lakes | Florida | 33016 | — |
| Local Institution | Port Orange | Florida | 32127 | — |
| Local Institution | Bastrop | Louisiana | 71220 | — |
| Local Institution | Biloxi | Mississippi | 39532 | — |
| Local Institution | Kansas City | Missouri | 64131 | — |
| Local Institution | Chattanooga | Tennessee | 37421 | — |
| Local Institution | Germantown | Tennessee | 38138 | — |
| Pinnacle Clinical Research - Austin | Austin | Texas | 78757 | — |
| Local Institution | Edinburg | Texas | 78539 | — |
| Local Institution | McAllen | Texas | 78504 | — |
| Local Institution | San Antonio | Texas | 78215 | — |
| Local Institution | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04766476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2022 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04766476 live on ClinicalTrials.gov.